|
2002
|
Company founded to enhance ultrasound-based therapies;
Artenga from the art of engineering.
|
|
2004-5
|
Successful microbubble research projects; first
microbubble generators developed; technology transferred from Carleton
University.
|
|
2006
|
Microbubble generator animal tested; image enhancement
equivalent to commercial contrast agents
|
|
2006
|
Ontario Centres of Excellence Accelerator investment.
|
|
2006
|
MaRS Discovery District life sciences team commences
medical industry consulting support.
|
|
2007
|
Microbubble generators tested at three medical
institutions.
|
|
2007
|
Third generation microbubble generator developed
|
|
2007/08
|
Canada-wide Top 10 winner, emerging Life Sciences Company
|
|
2008
|
MGD5 microbubble generator version five product launch
|
|
2008
|
Microbubble generator delivered to the Ontario Veterinary
College at Guelph Ontario, Canada’s premier veterinary college
|
|
2008
|
Artenga part of a $25. M Ontario Research Fund project led
by Sunnybrook Health Sciences Centre
|
|
2008
|
In vivo therapeutic testing; Artenga microbubbles more effective than commercial
contrast agent
|
|
2008
|
Seed round investment closed
|
|
2008
|
MGD5’s in six institutions; first U.S. and European sales;
|
|
2008
|
Agreement signed for QRS/ISO13485 cartridge supply
|
